Skip to main content

Full Schedule

Full Schedule

  • Wednesday, October 23, 2024
  • 6:30 AM - 8:00 AM US PDT
    GenDx Tulip Dance Workout!
    While ASHI is disappointed that we are unable to hold the GenDx Tulip Run as we have in previous years, ASHI and GenDx still want to give attendees the option of a Wednesday morning workout that supports a local OPO, OneLegacy.  Even if you've never experienced a Richard Simmons "Sweatin' to the Oldies" workout, Arttie, our talented Richard Simmons impersonator, is sure to get you revved up, laughing and most importantly..sweatin'! 
    In the spirit of competition, there will be prizes awarded to the best dressed, most spirited, and supreme dancer.
  • 8:30 AM - 8:45 AM US PDT
    Sir Walter Bodmer Introduction to the Rose Payne Award
  • 8:45 AM - 9:30 AM US PDT
    The Rose Payne Award & Lecture: Immunogenetics Illuminating HLA-related Receptors: From Alloreactivity to Neurodegeneration
    Speaker: Marco Colonna, MD – Washington University School of Medicine
    Moderator: Marcelo A. Fernandez-Vina, PhD, F (ACHI) (he/him/his) – Department of Pathology Stanford University School of Medicine
    The Rose Payne Award was established in 1984 to honor a great scientist and to recognize her long-standing contributions to the field of immunogenetics and her support in the development of the society.
     CE: .15 CEC / 1 CME
  • 9:30 AM - 10:00 AM US PDT
    AM Break
  • 10:00 AM - 10:15 AM US PDT
    Scientific Awards Presentation
    Moderator: Melody Zhang, MD, A(ACHI) – Stanford University
    Speaker: Joseph Ladowski, MD, PhD – Duke University
    The Science and Technology Initiatives Committee better known as STIC will award two individuals for the Early Career Investigator and the Michael Schmiederer Research Science Award
  • 10:15 AM - 10:30 AM US PDT
    Human Immunology Report

    Speaker: James Mathew, PhD – Northwestern University

  • 10:30 AM - 12:00 PM US PDT
    Plenary II: Cancer Neoantigen Discovery from the HLA Perspective
    Speaker: Justin Balko, PharmD, PhD – Vanderbilt University Medical Center
    Speaker: Hannah Carter, PhD – University of California San Diego
    Speaker: Mark Yarmarkovich, PhD – NYU School of Medicine
    Moderator: Chang Liu, MD, PhD, A(ACHI) (he/him/his) – Washington University in St. Louis School of Medicine
    Moderator: Manli Shen, PhD – University of Kentucky
    This plenary session will discuss the pivotal role of HLA in cancer immunotherapy, highlighting the latest research and therapeutic innovations. The first presentation will explore the intricate relationships between HLA genotypes and the neoantigen landscape, revealing how these factors influence immune responses, affect cancer risk, and determine treatment outcomes. The second speaker will introduce the novel peptide-centric (PC)-CAR T cells that target intracellular tumor antigens, thereby expanding the therapeutic potential for solid tumors, with the first PC-CAR entering clinical trials in 2024. Given the essential role of HLA in peptide presentation, the loss of HLA in cancer would be detrimental. The third presentation will focus on the detection and implications of tumor-specific HLA gene downregulation, using advanced in situ immunohistochemistry to enhance our understanding of antigen presentation and resistance mechanisms in cancer immunotherapies. Prepare to be inspired by the transformative potential of these discoveries at the intersection of cancer biology, HLA, and immunotherapy!
    
    Session developed by Annette Jackson, Chang Liu, Jerry Morris and Cathi Murphey, program planning committee.
    
    To learn more please click here.
     CE: .23 CEC / 1.5 CME
  • 12:00 PM - 12:30 PM US PDT
    ASHI Lunch
    **NEW THIS YEAR**

    You asked and we heard you. This year all lunches will be provided for full conference attendees only in the ASHI lunch social room. For convenience, you will grab a to-go lunch and sit with your peers to enjoy some downtime, networking and new friends.
  • 12:40 PM - 1:35 PM US PDT
    User Group Meeting: CareDx: Future of Transplant Solutions: Innovation Across the Pre and Post-Transplant Journey
    **NEW THIS YEAR**

    Lunch will be provided from 12:00pm - 12:30pm in the ASHI lunch social room (Grand Ballroom E-F). Lunch will NOT be provided in individual User Group Meetings.
  • 1:40 PM - 2:35 PM US PDT
    User Group Meeting: Thermo Fisher Scientific: Opening New Doors: Novel Approaches for the HLA Laboratory
    **NEW THIS YEAR**

    Lunch will be provided from 12:00pm - 12:30pm in the ASHI lunch social room (Grand Ballroom E-F). Lunch will NOT be provided in individual User Group Meetings.
  • 2:45 PM - 4:15 PM US PDT
    Abstract IV: Bioinformatics and Beyond
    Speaker: Avik Bhattacharya, PhD – University of California San Francisco
    Speaker: Nilesh Chitnis, PhD – Baylor College of Medicine
    Speaker: Caleb Cornaby, PhD, F(ACHI) – Children's Hospital Los Angeles
    Speaker: Mitchell Ellison, PhD – UPMC
    Speaker: Steve Mack, PhD – UCSF
    Speaker: Ryan Urbanowicz, Assistant Professor – Cedars Sinai Medical Center
    Moderator: Deanna Fang, MD, A(ACHI) – UC San Diego
     CE: .23 CEC / 1.5 CME
  • 2:45 PM - 4:15 PM US PDT
    Workshop 4: Let’s Get Real, We are Virtually There: Best practices in HLA antibody interpretation and virtual crossmatching
    Speaker: Carey Killion, BS, MT(ASCP), CHS(ACHI) – KSL Diagnostics
    Speaker: James Lan, MD, FRCPC, D(ACHI) – University of British Columbia
    Speaker: Rob Liwski, MD, PhD, FRCPC, F(ACHI) – Dalhousie University
    Speaker: Sandra Tafulo, PhD (she/her/hers) – Instituto Português de Sangue e da Transplantação
    Moderator: Annette Jackson, PhD – Duke University
    Moderator: Alberto Cardoso Martins Lima, PhD (he/him/his) – IGEN/AFIP and Federal University of Parana
    Workshop 4, titled "Let’s Get Real, We are Virtually There", will focus on the important topic of Best Practices in HLA Antibody Interpretation and Virtual Crossmatching. Following on the success of Workshop 7 last year, and building on it, we plan to present three interesting HLA antibody cases to all ASHI members who registered for the annual meeting. Each case will include detailed clinical history, sensitization background, and HLA antibody SAB assay results, including raw Luminex csv files. This will allow you to analyze and interpret the antibodies as you would for your patients. However, here’s the twist: for each case, we will also request that you perform virtual crossmatches based on your antibody interpretations. We aim to gather the antibody interpretations and virtual crossmatch results from interested participants. These collective findings will be collated and analyzed for presentation during the workshop. We encourage many of you to share your insights and participate in this interactive, educational and informative session, which promises to be both informative and fun. Your contributions will be invaluable as we continue to develop Best Practices in HLA antibody Interpretation and Virtual Crossmatching.
    
    Session developed by Carey Killion, James Lan, Rob Liwski and Sandra Tafulo, program planning committee.
    
    To learn more please click here.
     CE: .23 CEC / 1.5 CME
  • 2:45 PM - 4:15 PM US PDT
    Workshop 5: 50+ Years of HLA Antigen, Allele, and Antibody Nomenclature: Moving Toward Integrated and Consistent Approaches for Clinical Practice
    Speaker: Marcelo A. Fernandez-Vina, PhD, F (ACHI) (he/him/his) – Department of Pathology Stanford University School of Medicine
    Speaker: Steven GE Marsh, PhD, FRCPath – Anthony Nolan Research Institute
    Speaker: Jerry Morris, MD, PhD, A(ACHI) – University of California San Diego
    Moderator: Steve Mack, PhD – UCSF
    Moderator: Doreen Sese, CHS – NYU Langone | Transplant Institute
    This session will review historical and current processes for achieving standardized Nomenclature of HLA factors. The need for periodic updates will be discussed, with special focus on current gaps resulting from outdated serological nomenclature The rationale for developing criteria for the definition of HLA antigens in silico will be presented. The resulting updates in assigning serologic antigens corresponding to the vast majority of HLA alleles defined by molecular methods will be presented. Implementation of these updates for their use in Clinical Histocompatibility practices will be discussed.
    
    Session developed by Marcelo Fernandez-Vina, Steve Mack, Jerry Morris and Doreen Sese, program planning committee.
     CE: .23 CEC / 1.5 CME
  • 4:15 PM - 4:45 PM US PDT
    PM Break
  • 4:45 PM - 5:15 PM US PDT
    Joint Directors & Laboratory Professionals Forum
    Speaker: Jerry Morris, MD, PhD, A(ACHI) – University of California San Diego
    The Organ Procurement and Transplantation Network (OPTN) Histocompatibility Committee applies evolving science and technology in transplant immunology to develop, implement, and inform OPTN bylaws, policies, and clinical guidance for organ donation and transplantation.  At this year's Combined Directors' and Technologists' Forum, OPTN Histocompatibility Chair Dr. Gerald Morris will provide an important update on behalf of the committee.
     CE: .08 CEC / .5 CME
  • 5:15 PM - 5:45 PM US PDT
    Director's Forum
    Speaker: Annette Jackson, PhD – Duke University
    Speaker: Chantale Lacelle, PhD, F(ACHI) – University of Texas Southwestern Medical Center
    Speaker: Ahmed Mostafa, MD, PhD, F(ACHI) – University of Saskatchwean
    The Directors Forum is a session geared toward doctoral members in attendance at the Annual Meeting. The agenda includes updates from the Directors’ Affairs, National Clinical Affairs, and the Science and Technology Initiatives Committees. This informational session also provides an opportunity for networking.
    

    To see the agenda please click here.
     CE: .08 CEC / .5 CME
  • 5:15 PM - 6:15 PM US PDT
    Laboratory Professional's Forum (formerly Technologist's Forum)
    The Laboratory Professionals Forum (formerly the Technologists’ Forum) is a session geared toward members of all levels in attendance at the Annual Meeting. This year’s agenda provides an opportunity for networking, as well as an opportunity to celebrate our contribution to the field of histocompatibility and immunogenetics and the ASHI community. 
    Being an organ donor herself, Dr. Hitchman recently hiked Mt. Kilimanjaro with other living organ donors to raise awareness for organ donation. This is her AMAZING story summed up in 40 minutes!  Arrive on time to be eligible to win prizes!
    Tell us what topics you would like to see at next year’s Laboratory Professionals Forum: Please click here.
     CE: .15 CEC / 1 CME